why was bpc 157 banned FDA's Overreach on Compounded Peptides BPC-157: A Prohibited Peptide and

Dogs 5075 lbs: 500 mcg daily Small dogs: Decreasing pet-specific dosing under veterinary advice

Early investigations focused on adipose tissue biology and lipid metabolism, where researchers observed activity involving pathways associated with fat metabolism and energy utilization

But that peripheral-only action means it does not suppress appetite, does not change energy expenditure through central pathways, and does not produce the dramatic caloric deficits that GLP-1 agonists like semaglutide or tirzepatide create

Whenever a patient reports symptoms of illness, we use those as clues to solve the mystery of whats causing those symptoms